Investor Overview
Company Overview
DataMEDS AI is building a scalable healthcare platform that combines technology, pharmacy, distribution, patient access and data-driven solutions. Through strategic acquisitions and partnerships, the company is expanding its capabilities and reach while connecting complementary businesses across the healthcare ecosystem.
For investors, the opportunity is straightforward: a growing portfolio of healthcare businesses supported by technology, AI and data, with multiple pathways for expansion and long-term value creation.
The global medication adherence market segment is growing and is quickly projected to reach $11.2 Billion by 2030.
Investor Presentation
12.85%
Annual revenue growth, resulting in a projected market volume of $28.77 Bn by 2027
$17.74B
2023 projected revenue in Health Care
84.4M
Projected users in the Health Care segment by 2027
$289B
Estimated healthcare costs due to prescription non-adherence
12.85%
Annual revenue growth, resulting in a projected market volume of $28.77 Bn by 2027
Press Releases
Governance
